Orforglipron
Jul 03, 2023
Eli Lilly’s Obesity Treatment Drug Candidates – A Show for the Competitors
On 26 June 2023, the rush to develop obesity therapies appeared to have raised the bar, as an experimental weight-loss drug from US pharma company Eli Lilly yielded the greatest effects of any treatment observed thus far. The American Diabetes Association’s annual meeting has brought the competitive dynamics of ...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
